NEK5
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| NIMA related kinase 5 | MIM:616731 | Ensembl:ENSG00000197168 | HGNC:HGNC:7748 | PA31549 | 13q14.3 |
GO terms in NEK5
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IEA | GO:0005524 | ATP binding |
| MF | IEA | GO:0046872 | metal ion binding |
| BP | IEA | GO:0006468 | protein phosphorylation |
| BP | IEA | GO:0051155 | positive regulation of striated muscle cell differentiation |
| BP | IEA | GO:2001056 | positive regulation of cysteine-type endopeptidase activity |
Gene expression in normal tissue: NEK5
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in NEK5
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD246 | NPC26 | 2 |
| iGMDRD329 | Merck60 | 1 |
| iGMDRD105 | Triptolide | 2 |
| iGMDRD271 | Brefeldin A | 2 |
| iGMDRD158 | NSC141540 | 4 |
| iGMDRD945 | ML214 | 3 |
| iGMDRD177 | Teniposide | 6 |
| iGMDRD211 | (1S,3R)-RSL3 | 2 |
| iGMDRD85 | Ursolic acid | 2 |
| iGMDRD341 | Triacsin c | 3 |
| iGMDRD560 | MK-2206 | 2 |
| iGMDRD512 | nutlin 3 | 4 |
| iGMDRD64 | Parbendazole | 2 |
| iGMDRD190 | Nilotinib | 1 |
| iGMDRD369 | TGX-115 | 2 |
| iGMDRD506 | Fedratinib | 1 |
| iGMDRD399 | Selumetinib | 3 |
| iGMDRD74 | Idarubicin | 3 |
| iGMDRD887 | Compound 23 citrate | 2 |
| iGMDRD870 | BRD63610 | 2 |
| iGMDRD318 | PAC-1 | 1 |
| iGMDRD441 | TW 37 | 1 |
| iGMDRD171 | Pemetrexed | 3 |
| iGMDRD679 | Bistramide A | 1 |
| iGMDRD280 | CYTOCHALASIN B | 3 |
| iGMDRD297 | Austocystin D | 3 |
| iGMDRD71 | Sparfosic acid | 2 |
| iGMDRD494 | Neopeltolide | 3 |
| iGMDRD670 | ML 210 | 2 |
| iGMDRD579 | PF750 | 3 |
| iGMDRD387 | CHIR-99021 | 1 |
| iGMDRD126 | Tipifarnib | 5 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in NEK5
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.